Intrinsic Value of S&P & Nasdaq Contact Us

MacroGenics, Inc. MGNX NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
43/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$9.44
+168.2%

Stock Statistics — MGNX

MacroGenics, Inc. (MGNX) has a market capitalization of $223.72M and trades at $3.52. The 52-week range is 0.99-3.54.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -3, Earnings Per Share (EPS) of $-1.18, annual revenue of $149.5M.

The stock has a beta of 1.10, operates in the Healthcare sector.

Trading Data
Current Price$3.52
52-Week Range0.99-3.54
Volume647.56K
Avg Volume (30D)1.12M
Market Cap$223.72M
Beta (1Y)1.10
Company
IPO Date2013-10-10
Employees341
CEOEric Blasius Risser
CountryUS
ExchangeNASDAQ Global Select
CurrencyUSD
ISINUS5560991094
CUSIP556099109
Income (Latest Year)
Revenue$149.5M
Gross Profit$106.32M
EBITDA$-65.67M
Operating Income$-72.84M
Net Income$-74.62M
EPS$-1.18
EPS Diluted$-1.18
Shares Outstanding$63.16M
Balance Sheet (Latest Year)
Total Assets$256.85M
Current Assets$219.94M
Cash & ST Investments$189.91M
Total Liabilities$201.26M
Total Debt$106.76M
Net Debt$49.55M
Total Equity$55.59M
Debt / Equity1.92
Valuation Ratios
P/E Ratio-3
P/S Ratio1.5
P/B Ratio4.02
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message